BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35205787)

  • 1. Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries.
    Han IW; Park J; Park EY; Yoon SJ; Jin G; Hwang DW; Jiang K; Kwon W; Xu X; Heo JS; Fu DL; Lee WJ; Bai X; Yoon YS; Yang YM; Ahn KS; Yuan C; Lee HK; Sun B; Park EK; Lee SE; Kang S; Lou W; Park SJ
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
    Sadowski SM; Pieterman CRC; Perrier ND; Triponez F; Valk GD
    Endocr Relat Cancer; 2020 Jun; 27(6):R145-R161. PubMed ID: 32229700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).
    Yang G; Ji M; Chen J; Chen R; Chen Y; Fu D; Hou B; Huang H; Jiang L; Jin K; Ke N; Li Y; Li Y; Liang H; Liu A; Luo J; Ni Q; Shao C; Shen B; Sheng W; Song B; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Wang J; Wang J; Wang W; Wang W; Wu Z; Xu J; Yan Q; Yang N; Yang Y; Yin X; Yu X; Yuan C; Zeng S; Zhang G; Zhang R; Zhou Z; Zhu Z; Shao C
    Int J Oncol; 2017 Feb; 50(2):567-574. PubMed ID: 28035372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
    Regenet N; Carrere N; Boulanger G; de Calan L; Humeau M; Arnault V; Kraimps JL; Mathonnet M; Pessaux P; Donatini G; Venara A; Christou N; Bachelier P; Hamy A; Mirallié E
    Surgery; 2016 Mar; 159(3):901-7. PubMed ID: 26590096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
    Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
    Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
    Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.
    Zhou B; Duan J; Yan S; Zhou J; Zheng S
    Oncol Lett; 2017 Mar; 13(3):1157-1164. PubMed ID: 28454228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Heidsma CM; van Roessel S; van Dieren S; Engelsman AF; Strobel O; Buechler MW; Schimmack S; Perinel J; Adham M; Deshpande V; Kjaer J; Norlen O; Gill AJ; Samra JS; Mittal A; Hoogwater FJH; Primavesi F; Stättner S; Besselink MG; van Eijck CHJ; Nieveen van Dijkum EJM
    Neuroendocrinology; 2022; 112(6):571-579. PubMed ID: 34343138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.
    Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N
    Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
    Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors.
    Figueira ERR; Ribeiro JF; Ribeiro TC; Jureidini R; Namur GN; Costa TN; Bacchella T; Cecconello I
    Gastroenterol Res Pract; 2021; 2021():6650386. PubMed ID: 33986797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
    Ge W; Zhou D; Xu S; Wang W; Zheng S
    Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.
    Tanaka M; Heckler M; Mihaljevic AL; Probst P; Klaiber U; Heger U; Schimmack S; Büchler MW; Hackert T
    Ann Surg Oncol; 2021 Mar; 28(3):1614-1624. PubMed ID: 32720049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.
    Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
    ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors.
    Cui Y; Khanna LG; Saqi A; Crapanzano JP; Mitchell JM; Sethi A; Gonda TA; Kluger MD; Schrope BA; Allendorf J; Chabot JA; Poneros JM
    Clin Endosc; 2020 Mar; 53(2):213-220. PubMed ID: 31302988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive
    Kim J; Hwang HK; Lee WJ; Kang CM
    World J Gastrointest Oncol; 2020 Oct; 12(10):1133-1145. PubMed ID: 33133382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors.
    Sugawara T; Rodriguez Franco S; Kirsch MJ; Colborn KL; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Del Chiaro M; Schulick RD
    JAMA Netw Open; 2023 Mar; 6(3):e234096. PubMed ID: 36976561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.